• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中澳地区严重社区获得性肺炎的流行病学和微生物学:一项回顾性研究。

Epidemiology and microbiology of severe community-acquired pneumonia in Central Australia: a retrospective study.

机构信息

University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Centre for Remote Health, Flinders NT, Flinders University, Alice Springs, Northern Territory, Australia.

出版信息

Intern Med J. 2022 Jun;52(6):1048-1056. doi: 10.1111/imj.15171. Epub 2022 May 31.

DOI:10.1111/imj.15171
PMID:33342052
Abstract

BACKGROUND

Severe community-acquired pneumonia (SCAP) has high mortality and morbidity.

AIMS

To describe the epidemiology and microbiology of SCAP in Central Australia.

METHODS

A retrospective epidemiological study describing the characteristics, incidence rates (IR) and microbiological aetiology of SCAP in Central Australia. Adult patients admitted to Alice Springs Hospital Intensive Care Unit (ICU) between 2011 and 2014 that fitted the Infectious Diseases Society of America and American Thoracic Society definition of SCAP were included. Medical records were reviewed and compared between indigenous and non-indigenous patients. Primary outcomes were incidence rate and microbiological aetiology of SCAP. Secondary outcomes were 30-day mortality, and ICU and hospital length of stay (LoS).

RESULTS

A total of 185 patents were included (156 indigenous; 29 non-indigenous). The overall SCAP IR per 1000 person-years was 3.24 (3.75 indigenous; 1.87 non-indigenous) with an IR difference of 2.71 after adjustment (P < 0.001). Those aged ≥50 years had an IR 74.8% higher than those younger. Male IR was 50% higher than females. There was a significant difference between indigenous and non-indigenous groups for age (48 vs 64 years), but not for 30-day mortality (7.7% vs 10.3%), ICU LoS (4.8 vs 4.6 days) and hospital LoS (10.9 vs 15.1 days) respectively. Likely causative pathogen(s) were identified in 117 patients; Streptococcus pneumoniae was the most common pathogen (28.2%), followed by Haemophilus influenzae (19.7%), Influenza A/B (16.2%) and Staphylococcus aureus (14.5%).

CONCLUSION

A high incidence of SCAP was observed in Central Australia, disproportionately affecting the indigenous population. Prevention strategies are imperative, as well as early identification of SCAP and appropriate empiric antibiotic regimens.

摘要

背景

严重社区获得性肺炎(SCAP)具有高死亡率和发病率。

目的

描述澳大利亚中部地区 SCAP 的流行病学和微生物学特征。

方法

这是一项回顾性流行病学研究,描述了澳大利亚中部地区 SCAP 的特征、发病率(IR)和微生物病因。纳入 2011 年至 2014 年期间符合美国传染病学会和美国胸科学会 SCAP 定义的入住爱丽丝泉医院重症监护病房(ICU)的成年患者。对病历进行回顾性分析,并比较了土著和非土著患者。主要结局是 SCAP 的发病率和微生物病因。次要结局是 30 天死亡率以及 ICU 和住院时间。

结果

共纳入 185 例患者(156 例土著;29 例非土著)。每 1000 人年的 SCAP 总发病率为 3.24(土著为 3.75;非土著为 1.87),调整后发病率差异为 2.71(P < 0.001)。年龄≥50 岁的患者发病率比年龄较轻的患者高 74.8%。男性发病率比女性高 50%。土著和非土著组在年龄(48 岁比 64 岁)方面有显著差异,但在 30 天死亡率(7.7%比 10.3%)、ICU 住院时间(4.8 天比 4.6 天)和住院时间(10.9 天比 15.1 天)方面无显著差异。在 117 例患者中确定了可能的病原体;肺炎链球菌是最常见的病原体(28.2%),其次是流感嗜血杆菌(19.7%)、甲型流感/乙型流感(16.2%)和金黄色葡萄球菌(14.5%)。

结论

在澳大利亚中部地区观察到 SCAP 发病率较高,土著人群受影响不成比例。需要采取预防策略,以及早期识别 SCAP 和适当的经验性抗生素治疗方案。

相似文献

1
Epidemiology and microbiology of severe community-acquired pneumonia in Central Australia: a retrospective study.中澳地区严重社区获得性肺炎的流行病学和微生物学:一项回顾性研究。
Intern Med J. 2022 Jun;52(6):1048-1056. doi: 10.1111/imj.15171. Epub 2022 May 31.
2
Prediction accuracy of commonly used pneumonia severity scores in Aboriginal patients with severe community-acquired pneumonia: a retrospective study.常用肺炎严重程度评分在原住民重症社区获得性肺炎患者中的预测准确性:一项回顾性研究。
Intern Med J. 2023 Jan;53(1):51-60. doi: 10.1111/imj.15534. Epub 2022 Jul 29.
3
Evolution over a 15-year period of the clinical characteristics and outcomes of critically ill patients with severe community-acquired pneumonia.15年间重症社区获得性肺炎危重症患者临床特征及预后的演变
Med Intensiva. 2016 May;40(4):238-45. doi: 10.1016/j.medin.2015.07.005. Epub 2015 Sep 29.
4
Etiology, Treatments, and Outcomes of Patients With Severe Community-Acquired Pneumonia in a Large U.S. Sample.美国大样本中重症社区获得性肺炎患者的病因、治疗方法和结局。
Crit Care Med. 2022 Jul 1;50(7):1063-1071. doi: 10.1097/CCM.0000000000005498. Epub 2022 Feb 22.
5
Application and comparison of scoring indices to predict outcomes in patients with healthcare-associated pneumonia.应用和比较评分指标预测医疗相关性肺炎患者的结局。
Crit Care. 2011;15(1):R32. doi: 10.1186/cc9979. Epub 2011 Jan 19.
6
[Timing of sequential noninvasive mechanical ventilation following early extubation in aged patients with severe community-acquired pneumonia].老年重症社区获得性肺炎患者早期拔管后序贯无创机械通气的时机
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):324-329. doi: 10.3760/cma.j.cn121430-20191224-00072.
7
Guidelines for severe community-acquired pneumonia in the western world.西方世界重症社区获得性肺炎指南。
Neth J Med. 1999 Sep;55(3):110-7. doi: 10.1016/s0300-2977(99)00071-6.
8
[Severe community-acquired pneumonia admitted at the intensive care unit: main clinical and bacteriological features and prognostic factors: a Tunisian experience].[重症监护病房收治的重症社区获得性肺炎:主要临床和细菌学特征及预后因素:突尼斯的经验]
Rev Pneumol Clin. 2014 Oct;70(5):253-9. doi: 10.1016/j.pneumo.2014.03.001. Epub 2014 May 27.
9
Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination.β-内酰胺类-呼吸喹诺酮类与β-内酰胺类-大环内酯类联合治疗重症社区获得性肺炎。
Acta Anaesthesiol Scand. 2013 May;57(5):587-93. doi: 10.1111/aas.12081. Epub 2013 Feb 5.
10
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain.头孢洛林治疗严重社区获得性肺炎:意大利和西班牙真实世界的两中心经验。
Int J Antimicrob Agents. 2020 Apr;55(4):105921. doi: 10.1016/j.ijantimicag.2020.105921. Epub 2020 Feb 14.

引用本文的文献

1
Effects of Antibiotic De-Escalation on Outcomes in Severe Community-Acquired Pneumonia: An Inverse Propensity Score-Weighted Analysis.抗生素降阶梯治疗对重症社区获得性肺炎预后的影响:一项逆概率加权分析
Antibiotics (Basel). 2025 Jul 17;14(7):716. doi: 10.3390/antibiotics14070716.
2
Comparison of initial empirical antibiotic regimens in severe community-acquired pneumonia: a network meta-analysis.重症社区获得性肺炎初始经验性抗生素治疗方案的比较:一项网状Meta分析。
BMC Pulm Med. 2025 May 20;25(1):246. doi: 10.1186/s12890-025-03695-w.
3
Respiratory carriage of hypervirulent Klebsiella pneumoniae by indigenous populations of Malaysia.
马来西亚本土人群中高毒力肺炎克雷伯菌的呼吸道携带情况。
BMC Genomics. 2024 Apr 17;25(1):381. doi: 10.1186/s12864-024-10276-4.
4
Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study.验证一种新型每周三次的血液透析后头孢曲松方案在感染的澳大利亚原住民患者中的应用:一项群体药代动力学研究。
J Antimicrob Chemother. 2023 Aug 2;78(8):1963-1973. doi: 10.1093/jac/dkad190.
5
Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia.伊拉克社区获得性肺炎患者肺炎克雷伯菌中扩展谱β-内酰胺酶。
Rev Assoc Med Bras (1992). 2022 Jun 24;68(6):833-837. doi: 10.1590/1806-9282.20220222. eCollection 2022.